ShRNA-mediated silencing of AKR1B10 expression in HCC cells resulted in increased cell apoptosis, decreased colony formation and size, and enhanced cytoreductive response following exposure to doxorubicin chemotherapy 17. This evidence concerns the gene AKR1B10 and hepatocellular carcinoma.